December 13, 2022 — A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients without ...
December 12, 2022 — The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between ...
December 12, 2022 — Edwards Lifesciences Corporation announced that following regular succession planning discussions ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 12, 2022 — US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza ...
December 9, 2022 — BioSig Technologies, Inc. an advanced digital signal processing technology company delivering ...
December 9, 2022 — The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 9, 2022 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...
December 8, 2022 — Heart disease is the number one killer in the U.S., and high-fidelity monitoring is the beginning of ...
December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical ...
December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...
December 7, 2022 — While heart disease is a leading cause of death in the United States, most people can be treated with ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 7, 2022 — Compared with team-based care alone, the addition of a computerized clinical decision support system ...
December 7, 2022 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
December 7, 2022 — Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for ...